1 Simpson IN,O' Challaghem. Principal beta-lacta-mase responsible for resistance to beta-lactamase antibiotics in urine tract infections. Antimicro Agents and Chemother,1980,17:929 2 戴自英,主编.临床抗菌药物学.第一版,北京:人民卫生出版社,1985:6 3 Amsterdam D.The new NCCIS susceptibility documents. NCCLS interpretative table. Antimicrobic newsletter,1989,6(1):144 4 王容,刘卫.氧氟沙星与哌拉西林单用或联台应用的抗生素后效应.中国抗生素杂志,1993,18(5):383 5 周贵民,张淑兰,张秀珍,等.北京四家医院分离菌株对12种抗生素的耐药率.北京:第三届中日化学疗法研讨会讲演摘录,1994:33. 6 王彤,钟巍,李曼宁,等.Sulperazone等抗生素对β-内酰胺酶的稳定性比较.北京:第一届全国抗菌药物临床药理学会议论文集. 1995:77 7 Fasola EI,Fasching CE,Peterson LR.Molecular correlation between in vitro and in vivo activity of beta-lactam and beta-lactamase inhibitor combinations against methicillin-resistant Staphylococcus aureus. J Lab Clin Med,1995,125(2):200 8 吕媛. β-内酰胺酶抑制剂与β-内酰胺类抗生素联合应用的抗菌作用评价.北京:全国抗感染药物临床评价学术研讨会论文集,1996:72 9 Mark AC,Diecter WC.Activity of cefoperazone and two beta-lactamase inhibitor,sulbactum and clavulanic acid,against bactericides spp. correlated with betalacta-mase production. Antimicro Agents and Chemother,1982,22:398 10 Novelli A,Mazzei T,Fallani S,et al.In vitro postantibiotic effect and postantibiotic leukocyte enhancement of thbramycin. J Chemother,1995,7(4):355 11 王选锭,,原双晋,刘富光,等.头孢唑啉/舒巴坦对90株产酶菌的体外活性.北京:全国抗感染药物临床评价学术研讨会论文集,1996:114 |